What are the competency requirements for clinical pharmacist verification of systemic anti-cancer therapy (SACT) prescribed within a clinical trial? A consensus study.

导出原文传递

翻译打印收藏纠错

作者： Nikki,Gilluley ^[1] ; Marion,Bennie ^[2] ; Ben,Elliott ^[1]

作者单位： Strathclyde Institute of Pharmacy & Biomedical Sciences (SIPBS), University of Strathclyde, Glasgow, UK. ^[1] NHS Lothian Pharmacy Service, Edinburgh, UK. ^[2]

关键词 SACT Systemic anticancer therapy clinical trial competency pharmacist

主题词临床工作能力(Clinical Competence);多数赞同(Consensus);人类(Humans);肿瘤(Neoplasms);药剂师(Pharmacists);公费医疗(State Medicine)

DOI 10.1177/10781552211031962

PMID 34250848

发布时间 2022-09-12

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览2

Journal of oncology pharmacy practice

2022年28卷7期

1524-1533页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

What are the competency requirements for clinical pharmacist verification of systemic anti-cancer therapy (SACT) prescribed within a clinical trial? A consensus study.

Journal of oncology pharmacy practice

相似文献

Journal of oncology pharmacy practice

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

What are the competency requirements for clinical pharmacist verification of systemic anti-cancer therapy (SACT) prescribed within a clinical trial? A consensus study.

Journal of oncology pharmacy practice

相似文献

Journal of oncology pharmacy practice

相关期刊

检索历史清除